๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin

โœ Scribed by Thomas M. Hyers; Alex C. Spyropoulos; For the INNOVATE Investigators

Publisher
Springer US
Year
2007
Tongue
English
Weight
164 KB
Volume
24
Category
Article
ISSN
0929-5305

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Inhalable liposomes of low molecular wei
Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism
โœ Shuhua Bai; Fakhrul Ahsan ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 456 KB

This study tests the feasibility of inhalable pegylated liposomal formulations of low molecular weight heparin (LMWH) for treatment of two clinical manifestations of vascular thromboembolism: deep vein thrombosis (DVT) and pulmonary embolism (PE). Conventional distearoyl-sn-glycero-3-phosphoethanola

Home treatment of deep venous thrombosis
Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism
โœ Enric Grau; Jose M. Tenias; Esperanza Real; Jose Medrano; Rosario Ferrer; Emilio ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 37 KB ๐Ÿ‘ 2 views

## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3โ€“6 mon